Cyclosporin A and methotrexate are equally effective in reducing T cell numbers in psoriatic skin lesions but have no consistent effect on IFN-γ and IL-4 expression in psoriatic skin in situ

Archives of Dermatological Research

Volumn 294, Issue 12, 2003, Pages 559-562

  Piskin, Gamze ^a   Heydendael, Vera M R ^a   De Rie, Menno A ^a   Bos, Jan D ^a   Teunissen, Marcel B M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cyclosporin A; IFN ; IL 4; Methotrexate; Psoriasis; T cell

Indexed keywords

CYCLOSPORIN A; FOLIC ACID; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 4; METHOTREXATE;

ADULT; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL DENSITY; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; HISTOPATHOLOGY; HUMAN; KERATINOCYTE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TIME SERIES ANALYSIS;

EID: 0037353293     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-002-0353-8     Document Type: Article

References (16)

1. Bos JD, de Rie MA (1999) The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today 20:40-46
2. Austin LM, Ozawa M, Kikuchi T, Walters IB, et al (1999) The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 113:752-759
3. Szabo SK, Hammerberg C, Yoshida Y, et al (1998) Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets. J Invest Dermatol 111:1072-1078
4. Asadullah K, Volk H-D, Sterry W (2002) Novel immunotherapies for psoriasis. Trends Immunol 23:47-53
5. Asadullah K, Docke WD, Ebeling M, et al (1999) Interleukin-10 treatment of psoriasis: clinical results of a phase 2 trial. Arch Dermatol 135:187-192
6. Trepicchio WL, Ozawa W, Walters IB, et al (1999) Interleukin-11 therapy selectively downregulates type 1 cytokine proinflammatory pathways in psoriasis lesions. J Clin Invest 104:1527-1537
7. Baker BS, Griffiths CE, Lambert S, Powles AV, et al (1987) The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis. Br J Dermatol 116:503-510
8. Gupta AK, Baadsgaard O, Ellis CN, Voorhees JJ, et al (1989) Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A. Arch Dermatol Res 281:219-226
9. Genestier L, Paillot R, Fournel S, Ferraro C, et al (1998) Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest 102:322-328
10. Fredricksson T, Petterson U (1978) Severe psoriasis: oral therapy with a new retinoid. Dermatologica 157:238-244
11. Gottlieb AB, Grossman RM, Khandke L, Carter DM, et al (1992) Studies of the effect of cyclosporine in psoriasis in vivo: combined effects on activated T lymphocytes and epidermal regenerative maturation. J Invest Dermatol 98:302-309
12. Servitje O, Bordas X, Seron D, Vidaller A, Moreno A, Curco N, Sais G, Peyri J (1996) Changes in T-cell phenotype and adhesion molecule expression in psoriatic lesions after low dose cyclosporin therapy. J Cutan Pathol 23:431-436
13. Weinstein GD, Jeffes E, McCullough JL (1990) Cytotoxic and immunologic effects of methotrexate in psoriasis. J Invest Dermatol 49:S52-S95
14. Constantin A, Loubet-Lescoulie P, Lambert N, Yassine-Diab B, et al (1998) Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction. Arthritis Rheum 41:48-57
15. Prens EP, van Joost TH, Hegmans JPJJ, Hooft-Benne KT, et al (1995) Effects of cyclosporine on cytokines and cytokine receptors in psoriasis. J Am Acad Dermatol 33:947-953
16. Campbell DE, Kemp AS (1997) Cyclosporin restores cytokine imbalance in childhood atopic dermatitis. J Allergy Clin Immunol 99:857-859